Future Market Insights (FMI) delivers key insights on the global bioprocessing analytics equipment market in an upcoming report titled “Bioprocessing Analytics Equipment Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”.
In terms of revenue, the market is anticipated to register a compound annual growth rate (CAGR) of 4.5% over the forecast period due to various factors, which are detailed in this report.
Bioprocessing analytics equipment market segmental analysis
The global bioprocessing analytics equipment market is segmented based on product type, application, end-user and region.
Based on product type, the market is segmented into osmometers and bioprocess analysers. Osmometers are the leading product type in the bioprocessing analytics equipment market over the forecast period.
North America is expected to gain popularity over the forecast period, driven by cell-based bioprocesses that are extensively utilised for therapeutic protein production. Manual monitoring of such bioprocesses is labour intensive and can lead to errors in the production process.
Due to rapid advancements in technology, manufacturers have developed integrated multi-functional analysers, which combine the functionality of different single analysers such as cell counters, osmometers, nutrient/electrolyte/metabolite bio-profile analysers into one technologically enabled novel sampling system. It analyses the culture medium automatically, and the integration of multiple functionalities allows feedback control of parameters and reduces error rates in bioprocessing.
The market is further categorised based on application in clinical and industrial applications. The industrial application segment is expected to lead in the global bioprocessing analytics equipment market during the assessment period. Demand for bioprocessing analytics equipment is anticipated to be the highest across various industries, and the industrial segment is projected to register a CAGR of 4.4% over the forecast period.
The market is further classified based on end-users. End-user segments include biopharmaceutical companies, contract research organisation (CRO), contract manufacturing organisations (CMO), academics and research institutes, and clinical diagnosis. Biopharmaceutical companies are the largest end-users of bioprocessing analytics equipment while demand for bioprocessing analytics equipment is expected to be the highest in Biopharma companies. This is anticipated to register a growth rate of 3.9% over the forecast period.
Bioprocessing analytics equipment market regional forecast
This report assesses trends that are driving the growth of each market segment at the global and regional level and offers potential takeaways that could prove substantially useful to manufacturers looking to enter the market.
The North America market is estimated to dominate the global bioprocessing analytics equipment market, accounting for a maximum revenue share of the market by the end of 2018. The Western Europe and the Asia-Pacific excluding China and Japan (APECJ) markets are collectively expected to account for around 39.2% of the total bioprocessing analytics equipment market share in terms of value by the end of 2018. Revenue from the market in APECJ is projected to expand at a CAGR of 5.9% over the forecast period.
To request a sample report, click here.
To read a comprehensive overview of the report, including a TOC, click here.